Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $330

سي إم إي إنك

CME Group Inc. Class A

CME

0.00

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ: CME) with a Overweight and raises the price target from $324 to $330.